Contineum Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $5.7M | $130.4M | $15.5M |
| FY2024 | $14.8M | $212.8M | $21.9M |
| FY2025 | $15.7M | $276.6M | $75.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $5.7M | $130.4M | $15.5M |
| FY2024 | $14.8M | $212.8M | $21.9M |
| FY2025 | $15.7M | $276.6M | $75.6M |